INSPIRE MEDICAL SYSTEMS INC (INSP) Fundamental Analysis & Valuation

NYSE:INSP • US4577301090

59.97 USD
+0.53 (+0.89%)
At close: Mar 11, 2026
59.97 USD
0 (0%)
After Hours: 3/11/2026, 7:05:48 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This INSP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Overall INSP gets a fundamental rating of 6 out of 10. We evaluated INSP against 184 industry peers in the Health Care Equipment & Supplies industry. While INSP has a great health rating, its profitability is only average at the moment. INSP is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. INSP Profitability Analysis

1.1 Basic Checks

  • INSP had positive earnings in the past year.
  • INSP had a positive operating cash flow in the past year.
  • In multiple years INSP reported negative net income over the last 5 years.
  • Of the past 5 years INSP 4 years had a positive operating cash flow.
INSP Yearly Net Income VS EBIT VS OCF VS FCFINSP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • The Return On Assets of INSP (16.03%) is better than 95.11% of its industry peers.
  • With an excellent Return On Equity value of 18.62%, INSP belongs to the best of the industry, outperforming 92.39% of the companies in the same industry.
  • INSP has a better Return On Invested Capital (5.75%) than 76.63% of its industry peers.
Industry RankSector Rank
ROA 16.03%
ROE 18.62%
ROIC 5.75%
ROA(3y)6.51%
ROA(5y)-0.53%
ROE(3y)7.56%
ROE(5y)-0.94%
ROIC(3y)N/A
ROIC(5y)N/A
INSP Yearly ROA, ROE, ROICINSP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K

1.3 Margins

  • Looking at the Profit Margin, with a value of 15.95%, INSP belongs to the top of the industry, outperforming 92.39% of the companies in the same industry.
  • INSP has a Operating Margin of 5.59%. This is in the better half of the industry: INSP outperforms 70.11% of its industry peers.
  • INSP's Gross Margin of 85.39% is amongst the best of the industry. INSP outperforms 94.57% of its industry peers.
  • INSP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.59%
PM (TTM) 15.95%
GM 85.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.64%
GM growth 5Y0.15%
INSP Yearly Profit, Operating, Gross MarginsINSP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. INSP Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), INSP is destroying value.
  • The number of shares outstanding for INSP has been reduced compared to 1 year ago.
  • INSP has more shares outstanding than it did 5 years ago.
  • INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
INSP Yearly Shares OutstandingINSP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
INSP Yearly Total Debt VS Total AssetsINSP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • INSP has an Altman-Z score of 9.69. This indicates that INSP is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 9.69, INSP belongs to the top of the industry, outperforming 90.22% of the companies in the same industry.
  • There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.69
ROIC/WACC0.58
WACC9.9%
INSP Yearly LT Debt VS Equity VS FCFINSP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • INSP has a Current Ratio of 6.08. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of INSP (6.08) is better than 80.98% of its industry peers.
  • INSP has a Quick Ratio of 4.56. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of INSP (4.56) is better than 79.35% of its industry peers.
Industry RankSector Rank
Current Ratio 6.08
Quick Ratio 4.56
INSP Yearly Current Assets VS Current LiabilitesINSP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. INSP Growth Analysis

3.1 Past

  • INSP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.09%, which is quite impressive.
  • The Revenue has grown by 13.60% in the past year. This is quite good.
  • Measured over the past years, INSP shows a very strong growth in Revenue. The Revenue has been growing by 51.20% on average per year.
EPS 1Y (TTM)45.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.87%
Revenue 1Y (TTM)13.6%
Revenue growth 3Y30.76%
Revenue growth 5Y51.2%
Sales Q2Q%12.25%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.33% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 9.35% on average over the next years. This is quite good.
EPS Next Y-21.33%
EPS Next 2Y1.51%
EPS Next 3Y12.02%
EPS Next 5Y18.33%
Revenue Next Year6.76%
Revenue Next 2Y7.68%
Revenue Next 3Y8.62%
Revenue Next 5Y9.35%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
INSP Yearly Revenue VS EstimatesINSP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
INSP Yearly EPS VS EstimatesINSP Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4 6

More info and screens

Find the best growth stocksShow best growing peers

4

4. INSP Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 23.89 indicates a rather expensive valuation of INSP.
  • Compared to the rest of the industry, the Price/Earnings ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 75.54% of the companies listed in the same industry.
  • INSP's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.15.
  • Based on the Price/Forward Earnings ratio of 30.37, the valuation of INSP can be described as expensive.
  • INSP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. INSP is cheaper than 70.11% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.27, INSP is valued a bit more expensive.
Industry RankSector Rank
PE 23.89
Fwd PE 30.37
INSP Price Earnings VS Forward Price EarningsINSP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 75.00% of the companies listed in the same industry.
  • INSP's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INSP is cheaper than 87.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.85
EV/EBITDA 18.3
INSP Per share dataINSP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The decent profitability rating of INSP may justify a higher PE ratio.
  • A more expensive valuation may be justified as INSP's earnings are expected to grow with 12.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.51%
EPS Next 3Y12.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INSP Dividend Analysis

5.1 Amount

  • INSP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INSP Fundamentals: All Metrics, Ratios and Statistics

INSPIRE MEDICAL SYSTEMS INC

NYSE:INSP (3/11/2026, 7:05:48 PM)

After market: 59.97 0 (0%)

59.97

+0.53 (+0.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11
Earnings (Next)05-04
Inst Owners120.91%
Inst Owner Change9.03%
Ins Owners1.39%
Ins Owner Change2.32%
Market Cap1.71B
Revenue(TTM)911.98M
Net Income(TTM)145.42M
Analysts73.6
Price Target95.55 (59.33%)
Short Float %13.69%
Short Ratio2.6
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)176.52%
Min EPS beat(2)81.33%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)151.77%
Min EPS beat(4)81.33%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)214.54%
EPS beat(12)12
Avg EPS beat(12)205.03%
EPS beat(16)16
Avg EPS beat(16)165.1%
Revenue beat(2)0
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-0.7%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-0.7%
Max Revenue beat(4)1.13%
Revenue beat(8)3
Avg Revenue beat(8)0.06%
Revenue beat(12)6
Avg Revenue beat(12)1.03%
Revenue beat(16)10
Avg Revenue beat(16)3.19%
PT rev (1m)-27.11%
PT rev (3m)-25.42%
EPS NQ rev (1m)-347.48%
EPS NQ rev (3m)-564.94%
EPS NY rev (1m)12.01%
EPS NY rev (3m)13.22%
Revenue NQ rev (1m)-5.2%
Revenue NQ rev (3m)-5.31%
Revenue NY rev (1m)-3.52%
Revenue NY rev (3m)-4.17%
Valuation
Industry RankSector Rank
PE 23.89
Fwd PE 30.37
P/S 1.88
P/FCF 21.85
P/OCF 14.66
P/B 2.19
P/tB 2.19
EV/EBITDA 18.3
EPS(TTM)2.51
EY4.19%
EPS(NY)1.97
Fwd EY3.29%
FCF(TTM)2.74
FCFY4.58%
OCF(TTM)4.09
OCFY6.82%
SpS31.9
BVpS27.32
TBVpS27.32
PEG (NY)N/A
PEG (5Y)N/A
Graham Number39.28
Profitability
Industry RankSector Rank
ROA 16.03%
ROE 18.62%
ROCE 6.28%
ROIC 5.75%
ROICexc 9.27%
ROICexgc 9.27%
OM 5.59%
PM (TTM) 15.95%
GM 85.39%
FCFM 8.61%
ROA(3y)6.51%
ROA(5y)-0.53%
ROE(3y)7.56%
ROE(5y)-0.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.64%
GM growth 5Y0.15%
F-Score7
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 275.84%
Cap/Sales 4.22%
Interest Coverage 371.93
Cash Conversion 180.21%
Profit Quality 53.97%
Current Ratio 6.08
Quick Ratio 4.56
Altman-Z 9.69
F-Score7
WACC9.9%
ROIC/WACC0.58
Cap/Depr(3y)567.8%
Cap/Depr(5y)515.09%
Cap/Sales(3y)4.29%
Cap/Sales(5y)3.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.87%
EPS Next Y-21.33%
EPS Next 2Y1.51%
EPS Next 3Y12.02%
EPS Next 5Y18.33%
Revenue 1Y (TTM)13.6%
Revenue growth 3Y30.76%
Revenue growth 5Y51.2%
Sales Q2Q%12.25%
Revenue Next Year6.76%
Revenue Next 2Y7.68%
Revenue Next 3Y8.62%
Revenue Next 5Y9.35%
EBIT growth 1Y41.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year683.86%
EBIT Next 3Y109.9%
EBIT Next 5Y69.99%
FCF growth 1Y-13.88%
FCF growth 3Y216.73%
FCF growth 5YN/A
OCF growth 1Y-10.19%
OCF growth 3Y116.23%
OCF growth 5YN/A

INSPIRE MEDICAL SYSTEMS INC / INSP FAQ

What is the ChartMill fundamental rating of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

ChartMill assigns a fundamental rating of 6 / 10 to INSP.


Can you provide the valuation status for INSPIRE MEDICAL SYSTEMS INC?

ChartMill assigns a valuation rating of 4 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.


How profitable is INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 6 / 10.


What are the PE and PB ratios of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

The Price/Earnings (PE) ratio for INSPIRE MEDICAL SYSTEMS INC (INSP) is 23.89 and the Price/Book (PB) ratio is 2.19.


What is the financial health of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 9 / 10.